Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids

Objective. To compare bone mineral density (BMD) in pts with systemic lupus erythematosus (SLE), treated and untreated by glucocorticoids (GC). Matherial and Methods. 30 females with reliable SLE were examined (APA, 1982), 15 had GC (prednisolone 7.5-60mg/day, median cumulative dose 10.7±6.6g) (1st...

Full description

Saved in:
Bibliographic Details
Main Authors: L A Archakova, N M Kosheleva, A V Smirnov, Z S Alekberova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2004-02-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1230
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839568697434308608
author L A Archakova
N M Kosheleva
A V Smirnov
Z S Alekberova
author_facet L A Archakova
N M Kosheleva
A V Smirnov
Z S Alekberova
author_sort L A Archakova
collection DOAJ
description Objective. To compare bone mineral density (BMD) in pts with systemic lupus erythematosus (SLE), treated and untreated by glucocorticoids (GC). Matherial and Methods. 30 females with reliable SLE were examined (APA, 1982), 15 had GC (prednisolone 7.5-60mg/day, median cumulative dose 10.7±6.6g) (1st group), 15 others did not take GC (2nd group). Groups were comparable by age, SLE course duration, body weight. All were females with normal menses period. BMD was assessed in low back vertebral region and femoral neck in standard projections on dichromatic X-ray densitometer QDR-1000 Plus (Hologic, USA) in absolute values (g/cm2) and T-index. Results. BMD in low back was statistically reliably lower in the 1st group as compared with the 2nd (0,918±0,118 and 1,036±0,156; p=0,027). In the left femoral neck there were no differences in mineralization of bone tissue (0,769±0,167 and 0,807±0,227; p=0,568), BMD decreasing in the studied bone region reliably prevailed among pts of the 1st group (n=ll) as compared with the 2nd (n=2) (p=0.003). Conclusion. SLE pis treated by GC demonstrated reliably lower indices of BMD in LI-L4 as compared with pts who were not treated by GC.
format Article
id doaj-art-d17d6b56fc1a4a32aa135a1ca3d7671f
institution Matheson Library
issn 1995-4484
1995-4492
language Russian
publishDate 2004-02-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-d17d6b56fc1a4a32aa135a1ca3d7671f2025-08-04T17:03:46ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922004-02-01421192310.14412/1995-4484-2004-13771170Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoidsL A ArchakovaN M KoshelevaA V SmirnovZ S AlekberovaObjective. To compare bone mineral density (BMD) in pts with systemic lupus erythematosus (SLE), treated and untreated by glucocorticoids (GC). Matherial and Methods. 30 females with reliable SLE were examined (APA, 1982), 15 had GC (prednisolone 7.5-60mg/day, median cumulative dose 10.7±6.6g) (1st group), 15 others did not take GC (2nd group). Groups were comparable by age, SLE course duration, body weight. All were females with normal menses period. BMD was assessed in low back vertebral region and femoral neck in standard projections on dichromatic X-ray densitometer QDR-1000 Plus (Hologic, USA) in absolute values (g/cm2) and T-index. Results. BMD in low back was statistically reliably lower in the 1st group as compared with the 2nd (0,918±0,118 and 1,036±0,156; p=0,027). In the left femoral neck there were no differences in mineralization of bone tissue (0,769±0,167 and 0,807±0,227; p=0,568), BMD decreasing in the studied bone region reliably prevailed among pts of the 1st group (n=ll) as compared with the 2nd (n=2) (p=0.003). Conclusion. SLE pis treated by GC demonstrated reliably lower indices of BMD in LI-L4 as compared with pts who were not treated by GC.https://rsp.mediar-press.net/rsp/article/view/1230systemic lupus erythematosusmineral bone densityglucocorticoids
spellingShingle L A Archakova
N M Kosheleva
A V Smirnov
Z S Alekberova
Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
Научно-практическая ревматология
systemic lupus erythematosus
mineral bone density
glucocorticoids
title Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
title_full Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
title_fullStr Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
title_full_unstemmed Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
title_short Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
title_sort mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
topic systemic lupus erythematosus
mineral bone density
glucocorticoids
url https://rsp.mediar-press.net/rsp/article/view/1230
work_keys_str_mv AT laarchakova mineralbonedensitycomparativeassessmentinpatientswithsystemiclupuserythematosustreatedandnottreatedwithglucocorticoids
AT nmkosheleva mineralbonedensitycomparativeassessmentinpatientswithsystemiclupuserythematosustreatedandnottreatedwithglucocorticoids
AT avsmirnov mineralbonedensitycomparativeassessmentinpatientswithsystemiclupuserythematosustreatedandnottreatedwithglucocorticoids
AT zsalekberova mineralbonedensitycomparativeassessmentinpatientswithsystemiclupuserythematosustreatedandnottreatedwithglucocorticoids